Intravesical Lactobacillus to Reduce Urinary Symptoms After Spinal Cord Injury
Status:
Recruiting
Trial end date:
2022-08-01
Target enrollment:
Participant gender:
Summary
The objectives of the proposed research among this population are: 1) to define clinically
meaningful change (i.e. differentiating states of health and illness) with respect to urinary
symptoms, urine inflammation, cultivable bacteria, and the urine ecosystem; and 2) to
determine the optimal intravesical Lactobacillus RhamnosusGG (LGG®) dose to be used to reduce
urinary symptoms in a future clinical trial.